valine has been researched along with Airflow Obstruction, Chronic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Beinke, S; Belyaev, NN; Braubach, P; Braun, A; Fieguth, HG; Hessel, EM; Jonigk, D; Lennon, MG; Obernolte, H; Saunders, KA; Schaudien, D; Sewald, K; Warnecke, G; Wilkens, L; Wronski, S; Zardo, P | 1 |
| Barjaktarevic, I; Barr, RG; Bowler, RP; Comellas, AP; Cooper, CB; Curtis, JL; Diao, W; Gu, T; Han, MK; Hansel, NN; He, B; Kanner, RE; Krishnan, JA; Labaki, WW; Martinez, FJ; McDonald, MN; Murray, S; O'Neal, WK; Paine, R; Peters, SP; Standiford, TJ; Stringer, KA; Woodruff, PG; Yeomans, L | 1 |
| Hawkins, NM; Huang, Z; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Pieper, KS; Solomon, SD; Swedberg, K; Velazquez, EJ | 1 |
| Ben Chibani, J; Daimi, H; Denden, S; Haj Khelil, A; Hassine, M; Knani, J; Lakhdar, R; Leban, N; Lefranc, G | 1 |
| De Castro, CL; Deutz, NE; Engelen, MP; Rutten, EP; Schols, AM; Wouters, EF | 1 |
| de la Roza, C; Jardi, R; Miravitlles, M; Rodriguez, F; Schaper, M; Vidal, R | 1 |
| Chan-Yeung, M; Choo, KL; Chu, CM; Ho, SP; Lam, WK; Mak, JC; Yew, WW; Yu, WC | 1 |
| Anand, IS; Barlera, S; Carretta, E; Cohn, JN; Latini, R; Maggioni, AP; Masson, S; Staszewsky, L; Tognoni, G; Wong, M | 1 |
3 trial(s) available for valine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atherosclerosis; Cause of Death; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Survival Rate; Tetrazoles; Time Factors; Valine; Valsartan | 2009 |
Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amino Acids, Branched-Chain; Body Composition; Body Weight; Humans; Isoleucine; Leucine; Male; Meals; Middle Aged; Milk Proteins; Phenylalanine; Pulmonary Disease, Chronic Obstructive; Tyrosine; Valine; Whey Proteins; Young Adult | 2012 |
Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cause of Death; Confidence Intervals; Creatinine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Inflammation; Male; Middle Aged; Norepinephrine; Pulmonary Disease, Chronic Obstructive; Survival Rate; Tetrazoles; Treatment Outcome; Troponin T; Valine; Valsartan | 2007 |
5 other study(ies) available for valine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene Signatures.
Topics: Aged; Antiviral Agents; Asthma; Bronchi; Epithelial Cells; Female; Gene Expression Profiling; Genome, Human; Host-Pathogen Interactions; Humans; Isoxazoles; Lung; Male; Middle Aged; Phenylalanine; Picornaviridae Infections; Pulmonary Disease, Chronic Obstructive; Pyrrolidinones; Rhinovirus; Valine | 2021 |
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.
Topics: Amino Acids; Female; Humans; Isoleucine; Leucine; Male; Metabolomics; Middle Aged; Patient Outcome Assessment; Proton Magnetic Resonance Spectroscopy; Pulmonary Disease, Chronic Obstructive; Smokers; Tryptophan; Valine | 2019 |
Relationship between glutathione S-transferase P1 polymorphisms and chronic obstructive pulmonary disease in a Tunisian population.
Topics: Aged; Case-Control Studies; Exons; Female; Glutathione; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Pulmonary Disease, Chronic Obstructive; Risk Factors; Tunisia; Valine | 2010 |
Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.
Topics: Aged; alpha 1-Antitrypsin Deficiency; Female; Forced Expiratory Volume; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Middle Aged; Polymorphism, Genetic; Pulmonary Disease, Chronic Obstructive; Smoking; Valine | 2005 |
Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD.
Topics: Aged; Catalase; China; Erythrocytes; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Pulmonary Disease, Chronic Obstructive; Smoking; Superoxide Dismutase; Valine | 2007 |